We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Liver Failure Linked to Acetaminophen Overdose

By HospiMedica staff writers
Posted on 22 Apr 2002
A study has found that the risk of liver failure and death is increased in patients admitted to a hospital's intensive care unit (ICU) with accidental acetaminophen poisoning, compared to patients who have taken an intentional overdose. More...
The reason is that accidental overdosers are more likely to be alcohol abusers and to go to the hospital later, both of which increase the risk of death. The study was published in Critical Care (2002;6:108-110; www.ccforum.com).

An overdose overwhelms the ability of the liver to process acetaminophen. The excess is processed into toxic chemicals and these can kill liver cells. US doctors analyzed the medical records of 93 patients hospitalized as the result of an overdose, of whom 80 were categorized as suicidal, or intentional overdoses, and 13 as accidental overdosers. The accidental overdosers did not do as well as those who had attempted suicide, in spite of the fact that their levels of acetaminophen were lower than those of patients who intentionally overdosed.

Further analysis showed that the accidental overdosers waited longer before going to the hospital, and treatment effectiveness by the drug N-acetylcysteine (NAC) is reduced if not provided within 12 hours. The analysis also revealed that the overdosers were more apt to be heavy drinkers of alcohol. The toxicity of acetaminophen is increased by alcohol, since the liver attempts to eliminate both the alcohol and the drug by a similar pathway.

Victims of acetaminophen poisoning are usually treated in the ICU, which places a large financial burden on hospitals, say the authors of the study. They believe that major cost savings could be accomplished by placing patients on medical floors rather than the ICU if they have intentionally overdosed and show no history of alcohol abuse.




Related Links:
Critical Care

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.